Answers are grounded in this paper and cite their sources.
Summarizes standardized diagnostic criteria and innate immune pathways in cardiac allograft rejection, highlighting strategies to improve post-transplantation outcomes.
PURPOSE OF REVIEW: This review summarizes the latest publications dealing with antibody-mediated rejection (AMR) and defines areas of controversy and future steps that may improve the outcome for patients with this virulent form of rejection. RECENT FINDINGS: Recent progress includes publication of standardized pathologic criteria for acute AMR by the International Society for Heart and Lung Transplantation (ISHLT) and guidelines for treatment of acute AMR by the American Heart Association, endorsed by ISHLT as well. Recently published review articles emphasize the important role of innate immune mechanisms, clarify the role of viral infection and provide insights into vascular biology and the role of innate effector populations, macrophages and dendritic cells. SUMMARY: Strategies for future studies are discussed in the context of these new findings and similar efforts undertaken by renal and liver allograft investigators.
No takes yet. Share an insight, caveat, or question.
Hammond et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: